These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9150741)

  • 21. [Molecular genetics of Alport syndrome].
    Yamazaki H; Saito A; Nakagawa Y; Arakawa M
    Nihon Rinsho; 1992 Dec; 50(12):3021-6. PubMed ID: 1491454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Mutation in a Kazakh Family with X-Linked Alport Syndrome.
    Baikara BT; Zholdybayeva EV; Rakhimova SE; Nigmatullina NB; Momynaliev KT; Ramanculov YM
    PLoS One; 2015; 10(7):e0132010. PubMed ID: 26168235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The importance of non-invasive genetic analysis in the initial diagnostics of Alport syndrome in young patients.
    Slajpah M; Meglic A; Furlan P; Glavac D
    Pediatr Nephrol; 2005 Sep; 20(9):1260-4. PubMed ID: 15942778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene.
    Fu XJ; Nozu K; Eguchi A; Nozu Y; Morisada N; Shono A; Taniguchi-Ikeda M; Shima Y; Nakanishi K; Vorechovsky I; Iijima K
    Clin Exp Nephrol; 2016 Oct; 20(5):699-702. PubMed ID: 26581810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deletions of the COL4A5 gene in patients with Alport syndrome.
    Netzer KO; Renders L; Zhou J; Pullig O; Tryggvason K; Weber M
    Kidney Int; 1992 Dec; 42(6):1336-44. PubMed ID: 1474765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe alport phenotype in a woman with two missense mutations in the same COL4A5 gene and preponderant inactivation of the X chromosome carrying the normal allele.
    Guo C; Van Damme B; Vanrenterghem Y; Devriendt K; Cassiman JJ; Marynen P
    J Clin Invest; 1995 Apr; 95(4):1832-7. PubMed ID: 7706490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alport syndrome: a genetic study of 31 families.
    M'Rad R; Sanak M; Deschenes G; Zhou J; Bonaiti-Pellie C; Holvoet-Vermaut L; Heuertz S; Gubler MC; Broyer M; Grunfeld JP
    Hum Genet; 1992 Dec; 90(4):420-6. PubMed ID: 1483700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations.
    Savige J; Storey H; Il Cheong H; Gyung Kang H; Park E; Hilbert P; Persikov A; Torres-Fernandez C; Ars E; Torra R; Hertz JM; Thomassen M; Shagam L; Wang D; Wang Y; Flinter F; Nagel M
    PLoS One; 2016; 11(9):e0161802. PubMed ID: 27627812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
    Heidet L; Gubler MC
    Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene.
    Renieri A; Bruttini M; Galli L; Zanelli P; Neri T; Rossetti S; Turco A; Heiskari N; Zhou J; Gusmano R; Massella L; Banfi G; Scolari F; Sessa A; Rizzoni G; Tryggvason K; Pignatti PF; Savi M; Ballabio A; De Marchi M
    Am J Hum Genet; 1996 Jun; 58(6):1192-204. PubMed ID: 8651296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Segregation of hematuria in thin basement membrane disease with haplotypes at the loci for Alport syndrome.
    Buzza M; Wilson D; Savige J
    Kidney Int; 2001 May; 59(5):1670-6. PubMed ID: 11318937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].
    Endreffy E; Ondrik Z; Kemény E; Vas Z; Maróti Z; Lencse G; Bereczki C; Haszon I; Túri S; Iványi B
    Orv Hetil; 2005 Dec; 146(52):2647-53. PubMed ID: 16468607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Collagen type IV nephropathy: genetic heterogeneity examinations in affected Hungarian families.
    Endreffy E; Ondrik Z; Iványi B; Maróti Z; Bereczki C; Haszon I; Györke Z; Worum E; Németh K; Rikker C; Ökrös Z; Túri S
    Mol Cell Probes; 2011 Feb; 25(1):28-34. PubMed ID: 20951199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical and genetic features of the Alport 'syndromes'].
    Pescucci C; Longo I; Mari F; Scala E; Bruttini M; Caselli R; Renieri A
    G Ital Nefrol; 2005; 22(5):466-76. PubMed ID: 16267804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of large deletions in X linked Alport syndrome using competitive multiplex fluorescence polymerase chain reaction].
    Wang F; Zhang YQ; Ding J; Yu LX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):760-767. PubMed ID: 29045953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glomerular expression of type IV collagen chains in normal and X-linked Alport syndrome kidneys.
    Heidet L; Cai Y; Guicharnaud L; Antignac C; Gubler MC
    Am J Pathol; 2000 Jun; 156(6):1901-10. PubMed ID: 10854213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletion of the 5'exons of COL4A6 is not needed for the development of diffuse leiomyomatosis in patients with Alport syndrome.
    Sá MJ; Fieremans N; de Brouwer AP; Sousa R; e Costa FT; Brito MJ; Carvalho F; Rodrigues M; de Sousa FT; Felgueiras J; Neves F; Carvalho A; Ramos U; Vizcaíno JR; Alves S; Carvalho F; Froyen G; Oliveira JP
    J Med Genet; 2013 Nov; 50(11):745-53. PubMed ID: 23958657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dot-and-fleck retinopathy in Alport syndrome caused by a novel mutation in the COL4A5 gene.
    Blasi MA; Rinaldi R; Renieri A; Petrucci R; De Bernardo C; Bruttini M; Grammatico P
    Am J Ophthalmol; 2000 Jul; 130(1):130-1. PubMed ID: 11004279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males.
    Jais JP; Knebelmann B; Giatras I; Marchi M; Rizzoni G; Renieri A; Weber M; Gross O; Netzer KO; Flinter F; Pirson Y; Verellen C; Wieslander J; Persson U; Tryggvason K; Martin P; Hertz JM; Schröder C; Sanak M; Krejcova S; Carvalho MF; Saus J; Antignac C; Smeets H; Gubler MC
    J Am Soc Nephrol; 2000 Apr; 11(4):649-657. PubMed ID: 10752524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectrum of COL4A5 mutations in Finnish Alport syndrome patients.
    Martin P; Heiskari N; Pajari H; Grönhagen-Riska C; Kääriäinen H; Koskimies O; Tryggvason K
    Hum Mutat; 2000 Jun; 15(6):579. PubMed ID: 10862091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.